On the 22nd, KOSPI closed at 2733.68, down 44.97 points (1.62%) from the previous trading day. Employees are working in the dealing room of Hana Bank in Jung-gu, Seoul in the afternoon. (Photo by Yonhap News)

On the 22nd, KOSPI closed at 2733.68, down 44.97 points (1.62%) from the previous trading day. Employees are working in the dealing room of Hana Bank in Jung-gu, Seoul in the afternoon. (Photo by Yonhap News)

View original image


[Asia Economy Reporter Kum Boryeong] On the 22nd, the KOSPI and KOSDAQ fell, unable to withstand strong net selling by foreigners and institutions.


On that day, the KOSPI index closed at 2733.68, down 1.62% (44.97 points) from the previous trading day.


The KOSPI opened at 2772.03, down 0.24% (6.62 points) from the previous day, and maintained the 2760 level until 2 p.m., but then dropped sharply.


In the KOSPI market, individuals net bought 367.5 billion KRW, but foreigners and institutions net sold 148.1 billion KRW and 200.2 billion KRW, respectively.


By industry, retail (0.4%) and insurance (1.73%) rose, but medical precision (2.87%) and telecommunications (1.94%) fell.


Among the top 10 companies by market capitalization, all fell except NAVER. Samsung Electronics (0.96%), SK Hynix (3.02%), LG Chem (2.21%), Samsung Biologics (2.43%), and Celltrion (2.18%) declined.


The KOSDAQ index closed at 928.73, down 2.61% (24.85 points) from the previous trading day.


The KOSDAQ opened at 953.48, down 0.01% (0.1 points) from the previous day, but fell to the 920 level amid strong net selling by foreigners and institutions.


In the KOSDAQ market, individuals net bought 485.5 billion KRW. On the other hand, foreigners and institutions net sold 183.8 billion KRW and 215.9 billion KRW, respectively.


By sector, construction (0.69%) rose, but most sectors such as internet (3.52%), telecommunications equipment (2.66%), and metals (3%) were in decline.



None of the top 10 companies by market capitalization rose. Celltrion Healthcare (2.09%), Celltrion Pharm (4.1%), Seegene (4%), and HL Biopharma (1.84%) all fell.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing